A Private Consultation

An editorial guide to the ED care conversation

A reading publication. Not a clinic or patient portal.

Check the original

The source register

Open a record to find its source and the articles using it. A provider’s description is evidence of its published claims, not independent verification of clinical results.

CoreAge Rx: 4Play product description

Provider product description · Checked 2026-09-27

Read the original document ↗

Used in this reading

CoreAge Rx: 4Play offer and footer terms

Provider offer and service description · Checked 2026-09-27

Read the original document ↗

Used in this reading

DailyMed: Advagen sildenafil tablets, updated January 7, 2026

Exact product prescribing information · Checked 2026-09-27

Read the original document ↗

Used in this reading

FDA: Understanding the Risks of Compounded Drugs

Regulatory explanation · Checked 2026-09-27

Read the original document ↗

Used in this reading

NIDDK: Diagnosis of Erectile Dysfunction, reviewed October 2024

Government clinical information · Checked 2026-09-27

Read the original document ↗

Used in this reading

European Association of Urology: Management of Erectile Dysfunction

Specialty society clinical guideline · Checked 2026-09-27

Read the original document ↗

Used in this reading

Rex MD: Erectile Dysfunction Treatment

Provider ED service description · Checked 2026-09-27

Read the original document ↗

Used in this reading

Rex MD: Frequently Asked Questions

Provider service and billing FAQ · Checked 2026-09-27

Read the original document ↗

Used in this reading

Rex MD: Terms and Conditions, updated May 22, 2026

Provider contractual terms · Checked 2026-09-27

Read the original document ↗

Used in this reading

Lemonaid Health: Erectile Dysfunction service

Provider ED service description · Checked 2026-09-27

Read the original document ↗

Used in this reading

Lemonaid Health: Consent to Telehealth, updated November 6, 2024

Provider consent and clinical-service limitations · Checked 2026-09-27

Read the original document ↗

Used in this reading

Lemonaid Health: Erectile Dysfunction safety information

Provider exact-product safety descriptions · Checked 2026-09-27

Read the original document ↗

Used in this reading

Lemonaid Health: Refund Policy, updated September 27, 2023

Provider refund policy · Checked 2026-09-27

Read the original document ↗

Used in this reading

Lemonaid Health: Cancellation Policy, updated May 4, 2026

Provider cancellation policy · Checked 2026-09-27

Read the original document ↗

Used in this reading

NIDDK: Treatment for Erectile Dysfunction, reviewed October 2024

Government clinical information · Checked 2026-09-27

Read the original document ↗

Used in this reading

NIDDK: Symptoms and Causes of Erectile Dysfunction, reviewed October 2024

Government clinical information · Checked 2026-09-27

Read the original document ↗

Used in this reading

Lilly: Cialis tadalafil prescribing information, revised March 2026

Exact manufacturer prescribing information · Checked 2026-09-27

Read the original document ↗

Used in this reading

Bayer: Adempas riociguat prescribing information, revised August 2026

Exact manufacturer prescribing information · Checked 2026-09-27

Read the original document ↗

Used in this reading

NHLBI: Heart Attack Symptoms, updated March 24, 2022

Government emergency health information · Checked 2026-09-27

Read the original document ↗

Used in this reading

Hims — erectile dysfunction service

Official conditional ED offer, periodic check-ins and provider messaging; selected medicine, response timing and individual continuity are not verified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Hims & Hers — terms and conditions

Official terms updated April 23, 2026; independent medical groups, location, in-person escalation, cash payment and general subscription conditions. Weight-loss program rules are not applied to ED. · Checked 2026-09-29

Read the original document ↗

Used in this reading

NIDDK — diagnosis of erectile dysfunction

Federal clinical overview reviewed October 2024; history, examination and possible tests, not an individualized testing or clearance plan. · Checked 2026-09-29

Read the original document ↗

Used in this reading

FDA — understanding the risks of compounded drugs

Official explanation of compounded-drug approval and premarket-review limits; not an assessment of any selected provider preparation. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Ro — erectile dysfunction service

Official clinician-reviewed ED offer with conventional and compounded products; not proof of personal suitability, product superiority or a selected prescription. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Ro — terms and conditions of use

Official terms revised April 2, 2026; platform/practice/pharmacy roles, cash-payment restrictions and purchase-specific cancellation conditions. Body Membership provisions are not applied to ED. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Ro — important safety information for ED treatments

Official multi-product safety page; Sparks and Daily Rise Gummies are compounded and not FDA approved. Ingredient/tablet indications do not validate finished combinations or supply individual treatment directions. · Checked 2026-09-29

Read the original document ↗

Used in this reading

DailyMed — sildenafil tablets, Advagen Pharma Ltd.

Specific oral sildenafil ED tablet label updated January 7, 2026; contraindications and combination cautions provide product-specific context, not proof of a reviewed provider’s dispensed medicine or an approved compound. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Friday Plans — patient FAQ

Official service, selected-state access, billing, refund and safety answers; six-month prepayment versus three-month billing wording remains unresolved. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Friday Plans — terms of use

Official platform, medical-group and pharmacy roles and access limits; not an individual prescription or treatment agreement. · Checked 2026-09-29

Read the original document ↗

Used in this reading

ZipHealth — erectile dysfunction service

Official conditional ED offer with conventional and compounded-product qualifications; a selected formulation and price are not established. · Checked 2026-09-29

Read the original document ↗

Used in this reading

ZipHealth — terms of use

Official consultation, prescription-status cancellation, optional subscription and delivery provisions; unrelated branded weight-loss provisions are not imported into ED care. · Checked 2026-09-29

Read the original document ↗

Used in this reading

BlueChew — general FAQ

Official clinical, pharmacy, geographic and subscription descriptions; its twenty-four-hour cancellation statement differs from the terms. · Checked 2026-09-29

Read the original document ↗

Used in this reading

BlueChew — terms and conditions

Official recurring-charge and cancellation provisions dated July 20, 2026; forty-eight-hour deadline differs from the FAQ and no controlling account-specific interpretation is assumed. · Checked 2026-09-29

Read the original document ↗

Used in this reading

BlueChew — public service and product offer

Official compounded-product advertising and safety disclosures; no approval or generic-equivalence inference for the finished compounds. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Rugiet — Ready product page

Official compounded-product claims with two separately described internal survey populations; an inconsistent paroxetine sentence does not override the named three-ingredient formula. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Rugiet — terms and conditions

Official bundled-payment, refund and renewal provisions dated March 23, 2026; forty-eight-hour processing and seventy-two-hour billing clauses remain distinct and unresolved. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Rugiet — Ready important safety information

Official safety statement for compounded sildenafil, tadalafil and apomorphine; not an FDA-approved label or personal suitability assessment. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Strut Health — men’s sexual health catalog

Official distinct product and starting-price descriptions; catalog ingredients and unrelated hormone offers are not combined into one prescription. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Strut Health — Super Strut product and safety information

Official compounded-product page with an apomorphine-or-PT-141 alternative and inconsistent alpha-blocker wording; stability and comparative claims are not independently validated. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Strut Health — terms and conditions

Official prescription-subscription and service conditions; selected product, interval and charges remain unverified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Strut Health — refund policy

Official pharmacy-processing refund limit and damaged-item replacement conditions; not a treatment-results guarantee. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Strut Health support — refund policy

Official support explanation including notice before order processing; actual account cutoff and processing state are not verified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

RedBox Rx — erectile dysfunction service

Official service and price examples with different tablet strengths and quantities; provider-authored competitor prices are not independently refreshed quotations. · Checked 2026-09-29

Read the original document ↗

Used in this reading

RedBox Rx — terms of sale

Official pharmacy-choice, visit-fee, automatic-refill, refund and reimbursement conditions; Medicare Part D TrOOP language is not generalized into a beneficiary exclusion. · Checked 2026-09-29

Read the original document ↗

Used in this reading

RedBox Rx — sildenafil treatment information

Official product and safety description that separately identifies premature-ejaculation prescribing as off-label; no approval or manufacturer inference for an unidentified tablet. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Dr. B — erectile dysfunction care

Official AI-assisted intake followed by medical-provider review; starting consultation, possible video charge and separate pharmacy examples do not establish a personal total. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Dr. B — frequently asked questions

Official age, location, pharmacy, completed-consultation and record-sharing explanations; advertised review times and requested record transfers are not guaranteed outcomes. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Dr. B — terms of service

Official administrative and independent medical-practice roles with optional subscription conditions; no mandatory recurring ED membership is inferred. · Checked 2026-09-29

Read the original document ↗

Used in this reading

GoodRx Care: Care Direct ED assessment

Official clinician-review and messaging description; no individual clinical decision or continuing-care agreement verified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

GoodRx: Care Direct terms

Official platform, medical-group, pharmacy, telehealth-consent, age, location and funding conditions; specific to Care Direct, not Companion or discount coupons. · Checked 2026-09-29

Read the original document ↗

Used in this reading

NIDDK: diagnosis of erectile dysfunction

Independent history, examination and testing context, page last reviewed October 2024; not a universal test panel or evidence of an individual provider’s protocol. · Checked 2026-09-29

Read the original document ↗

Used in this reading

GoodRx: ED Care Direct service states

Official ED-specific North Dakota and South Carolina exclusions; service geography is not personal clinical eligibility. · Checked 2026-09-29

Read the original document ↗

Used in this reading

PlushCare: ED primary-care consultations

Official evaluation, referral and prescribing scope; excludes named testosterone and penile-injection services. No personal assessment or outcome verified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

PlushCare: membership information

Official membership and support features; not evidence that every message is a medical evaluation or that one doctor provides continuing care. · Checked 2026-09-29

Read the original document ↗

Used in this reading

PlushCare: service terms

Official clinical-service and account conditions; membership payment is not required for medical services. General minor-access rules do not establish pediatric ED care. · Checked 2026-09-29

Read the original document ↗

Used in this reading

PlushCare: appointment refund policy

Official payment treatment of assessment, advice, laboratory recommendations and referrals; separate membership limits do not establish an individual clinical outcome. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Sesame: ED consultation offer

Official video-consultation description with conditional prescribing; no selected professional or follow-up agreement verified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Sesame: service and telemedicine terms

Official independent-provider, age, location and service conditions; federal-program beneficiary certification is separate from insurance nonacceptance. · Checked 2026-09-29

Read the original document ↗

Used in this reading

CallonDoc: ED service page

Official public ED page and delivery description; selected treatment, total price and individual prescribing decision remain unconfirmed. · Checked 2026-09-29

Read the original document ↗

Used in this reading

CallonDoc: consultation and follow-up FAQ

Official ten-day follow-up episode, further-care, payment and administrative explanations; no individual testing or completed referral verified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Amazon One Medical: On-Demand ED service

Official dedicated On-Demand ED assessment; separate from membership-based primary care and personal eligibility. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Amazon One Medical: full On-Demand FAQ

Official 18–64 adult and government-payor restrictions, fourteen-day messaging and conditional refill rules; these do not apply automatically to all One Medical plans. · Checked 2026-09-29

Read the original document ↗

Used in this reading

One Medical: medical terms

Official clinical responsibility, US-location, consent, medication-history and remote-assessment limits; the specific On-Demand FAQ supplies its additional eligibility boundaries. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Maximus: Blood Flow program

Official physician-reviewed compounded offer and marketing statements; not independent evidence of a finished compound’s approval or clinical results. · Checked 2026-09-29

Read the original document ↗

Used in this reading

FDA: understanding compounded-drug risks

Independent explanation of lack of FDA approval and premarket review for compounded drugs; not a supplier-specific violation or outcome finding. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Maximus: general terms of use

Official clinical-practice and platform responsibilities, dated February 25, 2026 on the page; later Testosterone Protocol and Labs-specific provisions do not establish Blood Flow benefits. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Maximus: safety information

Official Blood Flow safety qualifications differ from some offer wording; not the label for a selected formula or a personal medicine-use recommendation. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Maximus: return and subscription policy

Official policy effective April 15, 2026; committed-term and remedy wording must be kept distinct from separately scoped savings-plan exceptions in the general terms. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Push Health: ED care requests

Official licensed-provider request service; named medicines do not verify a selected prescription or personal suitability. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Push Health: patient and provider FAQ

Official communication, laboratory-request and pharmacy-routing functions; the platform does not ship medicine or establish a completed clinical handoff. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Push Health: terms of use

Official independent medical-provider relationship, cash-basis/no-reimbursement conditions and age limits; no response deadline or individual continuing-care agreement verified. · Checked 2026-09-29

Read the original document ↗

Used in this reading

DrHouse: ED physician video visits

Official physician assessment and possible follow-up/laboratory/referral description; additional services may fall outside the first visit. · Checked 2026-09-29

Read the original document ↗

Used in this reading

DrHouse: refund and cancellation policy

Official clinical-work, identity and medication-history refund exclusions; historical membership language does not establish a current new-client membership. · Checked 2026-09-29

Read the original document ↗

Used in this reading

DrHouse: visit pricing and insurance

Official visit-level coverage statements, including Medicare and Medicaid distinctions; individual coverage is unverified and delivery has different rules. · Checked 2026-09-29

Read the original document ↗

Used in this reading

DrHouse: platform terms

Official adult eligibility and separate pharmacy-delivery terms; government-program delivery restrictions must not be generalized to every medical visit. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Optum Perks: Online Care for ED

Official clinical assessment offer beyond discount coupons; prescription, personal eligibility and outcome remain conditional. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Optum Perks: Online Care FAQ

Official questionnaire/video, business-hours response, coverage and record-sharing descriptions; records availability does not verify outside follow-up ownership. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Cleveland Clinic — Erectile Dysfunction Treatment

Official ED service description of the first assessment, conditional specialist coordination and virtual second opinions. Does not establish a personal prescription or follow-up timetable. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Cleveland Clinic — Center for Men's Health

Official clinical-center description naming ED care. Broad virtual-visit availability does not prove every examination or individual case can be managed remotely. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Mayo Clinic — Erectile Dysfunction Care at Mayo Clinic

Official multidisciplinary clinical-service account. Referral exceptions and medical-need prioritization apply; scheduling comparisons are provider claims, not personal deadlines. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Mayo Clinic — Erectile Dysfunction Diagnosis and Treatment

Official patient information on assessment, preparation and treatment selection. Possible tests and specialty involvement do not define a mandatory personal itinerary. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Duke Health — Male Sexual Dysfunction

Official clinical-service description, internally reviewed April 23, 2024. Primary-care and specialist roles are described; ED, ejaculation disorders and Peyronie’s care retain distinct contexts. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Duke Health — Duke Urology of Raleigh

Official clinic record listing ED care, underlying-health assessment and conditional referrals. General urologic follow-up wording does not establish an ED review calendar. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Northwestern Medicine — Erectile Dysfunction Specialists and Care Centers

Official Northwestern Memorial Hospital urology-service record. Observation, medical management and surgery are discussion options, not individual recommendations. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Northwestern Medicine — Erectile Dysfunction Treatments

Official description of underlying-cause care and treatment categories. Therapy-development history does not confirm an available finished medicine or pharmacy. · Checked 2026-09-29

Read the original document ↗

Used in this reading

UCLA Health — The Men's Clinic: Sexual Health

Official clinical-service description explicitly including ED. The public account does not specify an individual consultation sequence or exact prescription. · Checked 2026-09-29

Read the original document ↗

Used in this reading

UCLA Health — The Men's Clinic

Official clinic record including erectile-restoration care. Named clinical services do not establish personal appointment access, result ownership or continuing-care arrangements. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Stanford Health Care — Erectile Dysfunction

Official condition-specific record identifying clinical ED diagnosis and treatment. Listed clinics do not confirm a personal visit or remote-complete assessment. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Stanford Health Care — Urology Clinic in Palo Alto

Official clinic, patient-portal and referring-professional information. Record access and referral tracking do not demonstrate interpretation, automatic transfer or accepted clinical responsibility. · Checked 2026-09-29

Read the original document ↗

Used in this reading

NYU Langone Health — Erectile Dysfunction

Official ED clinical-service account describing individualized planning. It does not identify a patient’s completed assessment, medicine or continuing prescriber. · Checked 2026-09-29

Read the original document ↗

Used in this reading

NYU Langone Health — Medications for Erectile Dysfunction

Official treatment explanation connecting diagnostic findings and selection. Product examples do not confirm the exact supplied preparation, pharmacy or stock; technical details are not individual instructions. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Yale Medicine — Sexual Medicine and Reproductive Health

Official clinical-department description emphasizing concerns and goals. Read with the explicit ED program record; no individual visit or prescription is established. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Yale Medicine — Erectile Dysfunction

Official clinical-program description including cardiovascular-urology collaboration. Often-performed assessment is not a universal protocol; reassurance and recovery claims are not personal outcome evidence. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Johns Hopkins Medicine — Conditions We Treat: Erectile Dysfunction

Official indexed clinical-service record viewed September 29, 2026; the index reported a previous-day crawl and direct access was unavailable. Current appointment availability and an individual prescription are not confirmed. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Johns Hopkins Medicine — Prosthetic Urology

Official indexed service record viewed September 29, 2026; the index reported a previous-week crawl and direct access was unavailable. Counseling descriptions concern surgical candidates, not every ED medicine consultation. · Checked 2026-09-29

Read the original document ↗

Used in this reading

NIDDK — Treatment for Erectile Dysfunction

Federal patient information last reviewed October 2024. Underlying-cause uncertainty and clinician-led medicine review are general context, not evidence of personal suitability or an institution’s exact workflow. · Checked 2026-09-29

Read the original document ↗

Used in this reading

NIDDK — Diagnosis of Erectile Dysfunction

Federal patient information last reviewed October 2024. General history, examination and testing context does not prove a named institution’s operational protocol. · Checked 2026-09-29

Read the original document ↗

Used in this reading

NYU Langone Health — Erectile Dysfunction Diagnosis

Official clinical diagnosis account describing history, examination and conditional coordination with a mental-health provider when a medicine is suspected. Does not authorize stopping or changing treatment independently. · Checked 2026-09-29

Read the original document ↗

Used in this reading

Northwestern Medicine — Sexual Dysfunction

Official clinical-program account describing evaluation of hormonal, vascular, neurologic and psychological factors. Does not establish every patient’s tests or inter-practice handoff. · Checked 2026-09-29

Read the original document ↗

Used in this reading

SuperHealthy Rx: official ed offer

Provider primary source · Checked 2026-10-04

Read the original document ↗

Used in this reading

CoreAge Rx: shipping reference and service details

Homepage shipping reference; service and payment details supplied for this review, without a checkout or timed support test · Checked 2026-10-11

Read the original document ↗

Used in this reading

SuperHealthy Rx: shipping reference and service details

Homepage shipping reference; service and payment details supplied for this review, without a checkout or timed support test · Checked 2026-10-11

Read the original document ↗

Used in this reading

Ro: ED product catalog and plan quantities

Provider catalog; individual products, strengths and plan prices · Checked 2026-10-07

Read the original document ↗

Used in this reading

Ro: terms of use, payments and subscriptions

Provider policy; distinguish general subscription terms from Ro Body terms · Checked 2026-10-07

Read the original document ↗

Used in this reading

Ro Support: canceling an order

Provider support; processing orders and future shipments · Checked 2026-10-07

Read the original document ↗

Used in this reading

Ro Support: return and refund policy

Provider support; prescription return and refund restrictions · Checked 2026-10-07

Read the original document ↗

Used in this reading

Ro Support: changing your prescription

Provider support; clinical changes and follow-up · Checked 2026-10-07

Read the original document ↗

Used in this reading

EAU: Management of erectile dysfunction

Specialty guideline; clinical evaluation, treatment, and limited combination evidence · Checked 2026-10-07

Read the original document ↗

Used in this reading

Cui et al. (2015): daily tadalafil with as-needed sildenafil

Primary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI · Checked 2026-10-07

Read the original document ↗

Used in this reading

Ro: medication pricing

Provider source; advertised plan prices and quantities · Checked 2026-10-07

Read the original document ↗

Used in this reading

Ro: Sparks product details

Provider source; compounded formula, subscription pricing, and care process · Checked 2026-10-07

Read the original document ↗

Used in this reading

NIDDK: Diagnosis of erectile dysfunction

Government patient information · Checked 2026-10-07

Read the original document ↗

Used in this reading

MedlinePlus: Tadalafil

Drug information; standard tadalafil products · Checked 2026-10-07

Read the original document ↗

Used in this reading

DailyMed: Tadalafil prescribing information, including section 5.11

Prescribing label; not evidence for the 4Play combination · Checked 2026-10-07

Read the original document ↗

Used in this reading

FDA: Compounding and the FDA — questions and answers

Government guidance on compounded medications · Checked 2026-10-07

Read the original document ↗

Used in this reading

MedlinePlus: Sildenafil

Drug information; standard sildenafil products · Checked 2026-10-07

Read the original document ↗

Used in this reading

Ro: Daily Rise Gummies

Provider source; compounded tadalafil and billing intervals · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: current ED treatment catalog

Provider catalog; individual named offers and starting prices · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Hard Mints formulation safety library

Provider formulation document; includes options not confirmed in the main catalog · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims Support: canceling a subscription

Provider policy; 48-hour notice and orders already processing · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims Support: refund policy

Provider policy; no guaranteed refund after pharmacy processing · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims Support: when billing occurs

Provider policy; next order date, charge timing, and subscription intervals · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims Support: changing the next order date

Provider support; refill rescheduling differs from cancellation · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Hard Mints chewable ED medicines

Provider source; compounded formulations and advertised starting prices · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: 3-in-1 Pill formulation and safety

Provider formulation document; sildenafil, tadalafil and vitamin B12 · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Tadalafil Chews safety information

Provider formulation document; single-ingredient compounded tadalafil · Checked 2026-10-07

Read the original document ↗

Used in this reading

MedlinePlus: Vardenafil

Government patient drug information; standard products, not compounded equivalents · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Sex Rx + Hair Health formulations

Provider formulation document; versions with and without finasteride · Checked 2026-10-07

Read the original document ↗

Used in this reading

MedlinePlus: Oral minoxidil

Government patient drug information; systemic cardiovascular warnings · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Sex Rx + Testosterone Support formula

Provider formulation document; tadalafil and supplement blend, not testosterone replacement · Checked 2026-10-07

Read the original document ↗

Used in this reading

NIH Office of Dietary Supplements: Zinc

Government nutrient information; intake limits and interactions · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Sex Rx + Multivitamin formula

Provider formulation document; tadalafil and listed nutrients · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Climax Control and other product formulations

Provider article; tadalafil and fluoxetine identification, not an independent comparison · Checked 2026-10-07

Read the original document ↗

Used in this reading

MedlinePlus: Fluoxetine

Government patient drug information; antidepressant warnings and interactions · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: Sex Rx + Vitality Pro formula

Provider formulation document; tadalafil and atorvastatin · Checked 2026-10-07

Read the original document ↗

Used in this reading

MedlinePlus: Atorvastatin

Government patient drug information; statin use, monitoring and adverse effects · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: generic sildenafil

Provider source; standard tablets and advertised starting price · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: generic tadalafil tablets

Provider product page; daily and as-needed tablet options · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: branded Viagra

Provider product page; brand-name sildenafil and advertised price · Checked 2026-10-07

Read the original document ↗

Used in this reading

Hims: branded Cialis

Provider product page; branded tadalafil, distinct from generics · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: platform, care process, and safety information

Provider source; current featured product and service description · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: GOLD product and plan information

Provider source; four-ingredient compounded formulation · Checked 2026-10-07

Read the original document ↗

Used in this reading

FDA: Locate a state-licensed online pharmacy

Government pharmacy verification resource · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: GOLD published cost breakdown

Provider marketing article; approximate price examples, not a checkout quote · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: account and subscription questions

Provider policy; plan changes, one-order skips, and indefinite holds · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: shipping and delivery questions

Provider policy; destination availability, shipping, and renewal terms · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: returns and refunds policy

Provider policy; prescription returns and 24-hour cancellation notice · Checked 2026-10-07

Read the original document ↗

Used in this reading

Behnia et al. (2014): intranasal oxytocin in couples

Primary study; 29 healthy couples, different route and population from GOLD, abstract reviewed via NCBI · Checked 2026-10-07

Read the original document ↗

Used in this reading

Dula et al. (2001): sublingual apomorphine crossover trial

Primary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: product-specific approximate costs

Provider price examples; approximate and not necessarily consistent with other offer pages · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: combination and single-ingredient formulas

Provider article; listed strengths and formulations, not independent comparative evidence · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: product access and legacy-plan notice

Provider article; restricts certain products to existing enrolled customers; confirm account eligibility · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: VMAX product information

Provider product page; vardenafil and tadalafil strengths · Checked 2026-10-07

Read the original document ↗

Used in this reading

BlueChew: named product lineup

Provider article; product identification and marketing claims · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet: Ready product information

Provider source; current compounded product and consultation process · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet: Ready ingredients explained

Provider source; sildenafil, tadalafil, and apomorphine formulation · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet Support: membership options and inclusions

Provider support; plan intervals, shipping, and consultation fees · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet: terms and conditions

Provider policy; 72-hour subscription cancellation notice and refund eligibility · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet Support: canceling an order or subscription

Provider support; member portal steps and processing restrictions · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet Support: treatment response and refunds

Provider policy; refund exclusions and 24-hour order-change notice · Checked 2026-10-07

Read the original document ↗

Used in this reading

Pavone et al. (2004): apomorphine versus sildenafil

Primary crossover study; 34 evaluable participants, abstract reviewed via NCBI · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet: Daily Boost product information

Provider product page; tadalafil and DHEA combination · Checked 2026-10-07

Read the original document ↗

Used in this reading

Reiter et al. (1999): DHEA and erectile dysfunction

Primary placebo-controlled study, 40 selected men; indexed abstract reviewed · Checked 2026-10-07

Read the original document ↗

Used in this reading

Morales et al. (2009): androgens and sexual function

Primary randomized study, 86 men; indexed abstract reviewed; no significant sexual-function benefit · Checked 2026-10-07

Read the original document ↗

Used in this reading

Panchaprateep and Lueangarun (2020): oral minoxidil in 30 men

Primary open-label single-arm study, 24 weeks; indexed abstract reviewed, not a trial of a tadalafil combination · Checked 2026-10-07

Read the original document ↗

Used in this reading

Rugiet: Grower product information

Provider product page; tadalafil and oral minoxidil combination · Checked 2026-10-07

Read the original document ↗

Used in this reading

Goldstein et al. (1998): oral sildenafil trial

Retained primary paper; recheck restricted · Checked 2026-10-23

Read the original document ↗

Exhibit PDF (recheck restricted)

Used in this reading

Porst et al. (2006): daily tadalafil trial

Retained primary paper; recheck restricted · Checked 2026-10-23

Read the original document ↗

Exhibit PDF (recheck restricted)

Used in this reading

VIAGRA (sildenafil citrate) US prescribing information

Current prescribing information · Checked 2026-10-23

Read the original document ↗

Used in this reading

Cialis (tadalafil) prescribing information

Current prescribing information · Checked 2026-10-23

Read the original document ↗

Used in this reading

Understanding the risks of compounded drugs

FDA public information · Checked 2026-10-23

Read the original document ↗

Used in this reading